articleThe Lancet OncologyOct 22, 2010Closed access

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

ETEckhard ThielAKAgnieszka KorfelPMPeter MartusLKLothar KanzFGFrank Griesinger

Charité - Universitätsmedizin Berlin · University Children's Hospital Tübingen · +12 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

619
total citations
FWCI
20.79
Percentile
100%
References
40
Citations per year

Authors

21

Topics & keywords

Topics
Keywords
  • Medicine
  • Primary central nervous system lymphoma
  • Methotrexate
  • Radiation therapy
  • Chemotherapy
  • Regimen
  • Chemotherapy regimen
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.